Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jove

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Cancer Research|October 28, 1999
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivoG Niu, R Heller, R Catlett-Falcone, et al.
Journal of Virology|December 1, 1986
Genetic analysis of p60v-src domains involved in the induction of different cell transformation parametersR Jove, B J Mayer, H Iba, et al.
Molecular and Cellular Biology|August 1, 1992
Regulation of the junB gene by v-srcI Apel, C L Yu, T Wang, et al.
The Journal of Biological Chemistry|February 14, 1997
The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinaseL F Stancato, A M Silverstein, J K Owens-Grillo, et al.
Cellular Signalling|January 5, 2000
The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activityT C Lund, C Coleman, E Horvath, et al.
Cancer Research|April 20, 2001
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrestG Niu, K H Shain, M Huang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 7, 1998
Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potentialR Irby, W Mao, D Coppola, et al.
The Journal of Biological Chemistry|February 15, 1992
Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free systemK A Hutchison, B K Brott, J H De Leon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cellsM M Oshiro, T H Landowski, R Catlett-Falcone, et al.
Science (New York, N.Y.)|July 7, 1995
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoproteinC L Yu, D J Meyer, G S Campbell, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Cancer Research|October 28, 1999
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivoG Niu, R Heller, R Catlett-Falcone, et al.
Journal of Virology|December 1, 1986
Genetic analysis of p60v-src domains involved in the induction of different cell transformation parametersR Jove, B J Mayer, H Iba, et al.
Molecular and Cellular Biology|August 1, 1992
Regulation of the junB gene by v-srcI Apel, C L Yu, T Wang, et al.
The Journal of Biological Chemistry|February 14, 1997
The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinaseL F Stancato, A M Silverstein, J K Owens-Grillo, et al.
Cellular Signalling|January 5, 2000
The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activityT C Lund, C Coleman, E Horvath, et al.
Cancer Research|April 20, 2001
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrestG Niu, K H Shain, M Huang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 7, 1998
Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potentialR Irby, W Mao, D Coppola, et al.
The Journal of Biological Chemistry|February 15, 1992
Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free systemK A Hutchison, B K Brott, J H De Leon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cellsM M Oshiro, T H Landowski, R Catlett-Falcone, et al.
Science (New York, N.Y.)|July 7, 1995
Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoproteinC L Yu, D J Meyer, G S Campbell, et al.
Pageof 9